Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2008
12/31/2008WO2009002806A1 Pyrrolidinone, pyrrolidine-2, 5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
12/31/2008WO2009002802A2 Liquiritigenin and derivatives as selective estrogen receptor beta agonists
12/31/2008WO2009002770A1 6.5-pyrrolopiperidine tachykinin receptor antagonists
12/31/2008WO2009002768A2 Liquid bandage
12/31/2008WO2009002746A1 Dosing schedules of leukotriene synthesis inhibitors for human therapy
12/31/2008WO2009002652A2 Use of surfactants for treating mycobacterial infections
12/31/2008WO2009002553A1 Methods of treating multiple myeloma and resistant cancers
12/31/2008WO2009002538A2 Amorphous erlotinib, processes for the preparation thereof, and processes to prepare additional forms of erlotinib
12/31/2008WO2009002534A1 Imidazopyridinyl thiazolyl histone deacetylase inhibitors
12/31/2008WO2009002533A1 Inflammatory bowel disease therapies
12/31/2008WO2009002510A2 Crystalline polymorph of exemestane
12/31/2008WO2009002495A1 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
12/31/2008WO2009002490A2 Formulations of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino]sulfonyl}-2-thiophenecarboxamide
12/31/2008WO2009002489A2 Crystalline polymorph of 7-ethyl-10-hydroxycamptothecin
12/31/2008WO2009002469A1 Phthalazine compounds, compositions and methods of use
12/31/2008WO2009002433A1 Compositions and methods for treating skin disorders
12/31/2008WO2009002427A2 Methods of synthesizing cinacalcet and salts thereof
12/31/2008WO2009002425A2 Solubilized formulation of docetaxel without tween 80
12/31/2008WO2009002423A2 Polycyclic guanine derivatives and use thereof
12/31/2008WO2009002227A1 Rifabutin-based medicinal agent, nanoparticles-containing antimicrobial preparation and a method for the production thereof
12/31/2008WO2009002203A1 Polyfunctional fullerene c60 aminoacid derivatives
12/31/2008WO2009002166A1 Improving memory in subjects with mini-mental state examination of 24-26
12/31/2008WO2009002165A1 Lipid composition for improving brain function
12/31/2008WO2009002164A1 Food composition for prodromal dementia patients
12/31/2008WO2009002163A1 Supporting activities of daily living
12/31/2008WO2009002148A1 Food composition for prodromal dementia patients
12/31/2008WO2009002146A1 Supporting activities of daily living
12/31/2008WO2009001968A1 Benzazepine derivatives useful as vasopressin antagonists
12/31/2008WO2009001949A1 Pyrazolone derivative
12/31/2008WO2009001938A1 Hydrophilic composition containing hinokitiol
12/31/2008WO2009001937A1 Hydrophilic composition containing hinokitiol
12/31/2008WO2009001915A1 Substituted imidazole compound and use thereof
12/31/2008WO2009001857A1 Composition for ophthalmic disease associated with hypoxia or ischemia
12/31/2008WO2009001817A1 COMPOUND HAVING 11β-HSD1 INHIBITORY ACTIVITY
12/31/2008WO2009001805A1 Novel artificial n-linked sialo-sugar chain-containing polymer and method for producing the same
12/31/2008WO2009001787A1 Composition containing coenzyme q10
12/31/2008WO2009001786A1 Composition containing physiologically active substance
12/31/2008WO2009001764A1 Remedy or preventive for integration dysfunction syndrome
12/31/2008WO2009001730A1 Novel compound having β secretase inhibitory activity
12/31/2008WO2009001697A2 Microspheres having core/shell structure
12/31/2008WO2009001673A1 Atp-containing immunoadjuvant
12/31/2008WO2009001661A1 Medicinal agent for prevention or treatment of alzheimer's disease
12/31/2008WO2009001562A1 Compositions and methods of treating cancer
12/31/2008WO2009001551A1 Regulator of activity of bone-forming protein
12/31/2008WO2009001396A1 Disposable sterile ocular solution for corneal cross- linking of cheratocone, and process for production thereof
12/31/2008WO2009001356A2 Acyl-urea derivatives and uses thereof
12/31/2008WO2009001219A2 Immunocytokines for cancer treatment in combination with chemotherapeutic agents
12/31/2008WO2009001214A2 Thieno[2,3-d]pyrimidin-4(3h)-one, isoxazolo[5,4-d]pyrimidin-4(5h)-one and isothiazolo[5,4-d]pyrimidin-4(5h)-one derivatives as calcium receptor antagonists
12/31/2008WO2009001163A1 Lyophilized preparations of pantoprazole sodium for injection
12/31/2008WO2009001146A1 Pharmaceutical composition containing acetylcholine esterase inhibitor and method for the preparation thereof
12/31/2008WO2009001144A2 Pharmaceutical aerosol compositions comprising fluticasone
12/31/2008WO2009001132A1 Pyrazinone derivatives and their use in the treatment of lung diseases
12/31/2008WO2009001129A1 1-cyanocyclopropyl-derivatives as cathepsin k inhibitors
12/31/2008WO2009001128A1 1,2-cycl0hexane dicarboxamides as cathepsin inhibitors
12/31/2008WO2009001127A1 Cyanocyclopropylcarboxamides as cathepsin inhibitors
12/31/2008WO2009001126A1 Substituted piperidine derivatives and their use as antibaterial agents
12/31/2008WO2009001097A2 Substrate reduction therapy
12/31/2008WO2009001089A1 Fused thiazole derivatives as kinase inhibitors
12/31/2008WO2009001085A2 An inhalable composition comprising nicotine
12/31/2008WO2009001081A1 Therapeutic uses of cannabigerol
12/31/2008WO2009001046A2 [11c]methoxy-radiolabelled 2,3',4,5'-tetramethylstilbene (tms) and its preparation and use
12/31/2008WO2009001040A2 Treatment of depression
12/31/2008WO2009001021A1 Imidazopyridine derivatives useful as enzyme inhibitors for the treatment of cell proliferative and autoimmune diseases
12/31/2008WO2009000954A2 Use of estriol in low doses
12/31/2008WO2009000937A1 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
12/31/2008WO2009000935A1 Slimming composition
12/31/2008WO2009000926A1 Combinations of sap depleting agents and anti-sap antibodies
12/31/2008WO2009000909A2 Salts of perindopril
12/31/2008WO2009000907A2 Combination of picotamide with nafronyl
12/31/2008WO2009000878A1 Kallikrein 7 modulators
12/31/2008WO2009000877A1 Cysteine protease inhibitors
12/31/2008WO2009000853A2 Combination formulations comprising darunavir and etravirine
12/31/2008WO2009000843A2 Treatment of heart failure in non-human animal mammals by an aldosterone antagonist
12/31/2008WO2009000834A1 Method for the purification of mycophenolate mofetil
12/31/2008WO2009000832A2 Chemical compounds
12/31/2008WO2009000819A1 5-phenyl-1,3,4-oxadiazol-2-yl-acetyl-4-piperidinyl derivatives as cgrp receptor antagonists
12/31/2008WO2009000818A1 3-carbonylaminothiophene-2-carboxylic acids as hepatitis c virus inhibitors
12/31/2008WO2009000811A1 N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors
12/31/2008WO2009000798A1 Sildenafil n-oxide as prodrug
12/31/2008WO2009000797A1 N-oxides of venlafaxine and o-desmethylvenlafaxine as prodrugs
12/31/2008WO2009000745A1 Heterocyclic compounds for the treatment of tuberculosis
12/31/2008WO2009000663A1 Urea and carbamate derivatives as non-nucleoside reverse transcriptase inhibitors
12/31/2008WO2009000662A1 Isoxazole-imidazole derivatives
12/31/2008WO2009000592A1 Use of nitric oxide-releasing statins in the treatment of pulmonary arterial hypertension
12/31/2008WO2009000558A1 Synergistic combination of anthranilamide pyridinureas and benzamide derivatives
12/31/2008WO2009000552A2 Compositions for the treatment of hyperphenylalaninemia
12/31/2008WO2009000551A1 Use of a synergistic composition as a therapeutic agent or disinfectant
12/31/2008WO2009000489A1 Benzimidazole amido derivatives as kinase inhibitors
12/31/2008WO2009000473A2 Effervescent tablets for inhalatory use
12/31/2008WO2009000286A1 Improved pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof
12/31/2008WO2009000277A1 Treatment of urinary tract infections with a mixture of saponin and an antibiotic
12/31/2008WO2009000262A1 Electrophoretic transdermal application system
12/31/2008WO2009000210A1 Novel carbapenem derivatives
12/31/2008WO2009000163A1 1β- METHYLCARBAPENEM ANTIBIOTICS,THE PHARMACEUTICAL COMPOSITION AND USE THEREOF
12/31/2008WO2009000150A1 The use of sanchinoside in treating septicemia
12/31/2008WO2009000149A1 Use of notoginsenoside r1 in the preparation of the medicament for treating hepatic injuries
12/31/2008WO2009000146A1 Succinic acid-(5-androsten-17-one-3beta-ol)-diester solid dispersion, method for the production and the use thereof
12/31/2008WO2009000145A1 Use and preparation of paeoniflorin and the composition thereof
12/31/2008WO2009000132A1 Immediate release effervescent-formulation and preparing process thereof
12/31/2008WO2009000087A1 Substituted fused pyrimidines as antagonists of gpr105 activity
1 ... 2925 2926 2927 2928 2929 2930 2931 2932 2933 2934 2935 2936 2937 2938 2939 2940 2941 2942 2943 2944 2945 ... 7860